Glucagon-like peptide-1 (GLP-1) receptor agonist

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics natural incretin hormones to regulate blood glucose and promote weight loss. Available as FDA-approved Ozempic® for Type 2 diabetes, Wegovy® for chronic weight management, and Rybelsus® as the first oral GLP-1 medication. Clinical trials demonstrate exceptional efficacy with 14.9% average weight loss and 26% reduction in major cardiovascular events.

How it works

GLP-1 receptor agonist – mimics incretin hormones to regulate blood sugar, slow gastric emptying, and promote satiety for weight management

Weight Loss – Glucose control – Cardiovascular Protection